Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We analyzed the function of MIF and novel oncoantigen, DEPDC1, in malignant glioma. MIF bound directly to p53 and inhibited its function in brain tumor stem cells and glioma cells. MIF knockdown inhibited tumor progression in mouse brain tumor model. DEPDC1 promoted cell proliferation through NF-κB signaling pathway in glioma cells. DEPDC1 knockdown prolonged overall survival in mouse model using induced brain tumor stem cells. Our data suggested that MIF and DEPDC1 were useful target molecules for the treatment of glioma.
|